• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-65-150-120-P6
Medical Device Problem Codes Device Dislodged or Dislocated (2923); Activation Failure (3270)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/25/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2021, a percutaneous intervention was performed.During the intervention, a supera stent had dislodged from the delivery catheter and was removed from the patient.It is unknown at what point this issue occurred.There was no adverse patient sequela noted.No additional information was provided regarding this issue.
 
Additional Manufacturer Narrative
The device has been received.The investigation is not yet complete.A follow-up report will be submitted with the additional, relevant information.B1, product problem removed.B2, required intervention removed.H1, serious injury removed.H6, device code 2923 removed.H6, health effect code 4641 removed.
 
Event or Problem Description
Subsequent to the initial report, the additional information was received: the procedure was performed to treat the superficial femoral artery (sfa), heavily calcified lesion.The supera stent had been deployed at the sfa lesion site.During delivery catheter removal, the stent had explanted.There was no intervention reported.
 
Additional Manufacturer Narrative
The device was returned for analysis.The reported activation failure/ deployment issue was unable to be tested due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that during stent deployment interaction with the heavily calcified anatomy and/or manipulation of the device resulted in the noted sporadically bent outer sheath resulting in the ratchet being unable to properly engage/fully deploy the stent; thus resulting in reported activation failure/ deployment issue.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Common Device Name
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12787420
Report Number2024168-2021-10203
Device Sequence Number17142022
Product Code NIP
UDI-Device Identifier08717648226328
UDI-Public08717648226328
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2021
Device Model NumberS-65-150-120-P6
Device Catalogue NumberS-65-150-120-P6
Device Lot Number0010861
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/22/2021
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/25/2021
Supplement Date Received by Manufacturer11/16/2021
12/13/2021
Initial Report FDA Received Date11/10/2021
Supplement Report FDA Received Date12/07/2021
12/15/2021
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/08/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-